ES2170152T3 - Virus de la hepatitis g y clon molecular del mismo. - Google Patents
Virus de la hepatitis g y clon molecular del mismo.Info
- Publication number
- ES2170152T3 ES2170152T3 ES95922085T ES95922085T ES2170152T3 ES 2170152 T3 ES2170152 T3 ES 2170152T3 ES 95922085 T ES95922085 T ES 95922085T ES 95922085 T ES95922085 T ES 95922085T ES 2170152 T3 ES2170152 T3 ES 2170152T3
- Authority
- ES
- Spain
- Prior art keywords
- hgv
- hepatitis
- antigens
- methods
- sequences
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 208000006454 hepatitis Diseases 0.000 title abstract 3
- 231100000283 hepatitis Toxicity 0.000 title abstract 3
- 241000700605 Viruses Species 0.000 title abstract 2
- 239000000427 antigen Substances 0.000 abstract 4
- 102000036639 antigens Human genes 0.000 abstract 4
- 108091007433 antigens Proteins 0.000 abstract 4
- 238000000034 method Methods 0.000 abstract 3
- 229920001184 polypeptide Polymers 0.000 abstract 2
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 2
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 2
- 238000001514 detection method Methods 0.000 abstract 1
- 238000003745 diagnosis Methods 0.000 abstract 1
- 239000012634 fragment Substances 0.000 abstract 1
- 238000002955 isolation Methods 0.000 abstract 1
- 102000039446 nucleic acids Human genes 0.000 abstract 1
- 108020004707 nucleic acids Proteins 0.000 abstract 1
- 150000007523 nucleic acids Chemical class 0.000 abstract 1
- 238000002360 preparation method Methods 0.000 abstract 1
- 229960005486 vaccine Drugs 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/29—Hepatitis virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/78—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin or cold insoluble globulin [CIG]
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/576—Immunoassay; Biospecific binding assay; Materials therefor for hepatitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/24011—Flaviviridae
- C12N2770/24211—Hepacivirus, e.g. hepatitis C virus, hepatitis G virus
- C12N2770/24222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Biomedical Technology (AREA)
- Immunology (AREA)
- Virology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Zoology (AREA)
- Communicable Diseases (AREA)
- Animal Behavior & Ethology (AREA)
- Wood Science & Technology (AREA)
- Veterinary Medicine (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Physics & Mathematics (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Plant Pathology (AREA)
- Toxicology (AREA)
- Food Science & Technology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Analytical Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- General Chemical & Material Sciences (AREA)
- Cell Biology (AREA)
- Oncology (AREA)
Abstract
SE DESCRIBEN ANTIGENOS DE POLIPEPTIDO QUE SON INMUNORREACTIVOS CON SUEROS DE INDIVIDUOS QUE TIENEN UNA HEPATITIS NO A, NO B, NO C, NO D, NO E, AQUI DESIGNADA VIRUS DE HEPATITIS G (HGV). SE MUESTRAN REPLICACIONES DEL FRAGMENTO GENOMICO CORRESPONDIENTE QUE CONTIENEN POLINUCLEOTIDOS QUE CODIFICAN LAS SECUENCIAS DE MARCA DE LECTURA ABIERTA DE LOS POLIPEPTIDOS ANTIGENICOS. LOS ANTIGENOS SON UTILES EN METODOS DE DIAGNOSTICO PARA DETECTAR LA PRESENCIA DE HGV EN SUJETOS DE PRUEBA. LOS ANTIGENOS TAMBIEN SON UTILES EN PREPARADOS DE VACUNAS Y ANTICUERPOS. ADEMAS SE DESCRIBEN LAS SECUENCIAS DE CODIFICACION COMPLETAS DE DOS AISLADOS HGV. SE PRESENTAN METODOS PARA DETECCION SOBRE LA BASE DE ACIDO NUCLEICO DE HGV EN MUESTRAS Y TAMBIEN METODOS PARA EL AISLAMIENTO DE OTRAS SECUENCIAS GENOMICAS CORRESPONDIENTES AL HGV.
Applications Claiming Priority (8)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US24698594A | 1994-05-20 | 1994-05-20 | |
| US28555894A | 1994-08-03 | 1994-08-03 | |
| US28554394A | 1994-08-03 | 1994-08-03 | |
| US32972994A | 1994-10-26 | 1994-10-26 | |
| US34427194A | 1994-11-23 | 1994-11-23 | |
| US35750994A | 1994-12-16 | 1994-12-16 | |
| US38988695A | 1995-02-15 | 1995-02-15 | |
| PCT/US1995/006169 WO1995032291A2 (en) | 1994-05-20 | 1995-05-19 | Hepatitis g virus and molecular cloning thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ES2170152T3 true ES2170152T3 (es) | 2002-08-01 |
Family
ID=27569460
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES95922085T Expired - Lifetime ES2170152T3 (es) | 1994-05-20 | 1995-05-19 | Virus de la hepatitis g y clon molecular del mismo. |
Country Status (15)
| Country | Link |
|---|---|
| EP (1) | EP0763114B1 (es) |
| JP (2) | JPH10503642A (es) |
| KR (1) | KR100394693B1 (es) |
| CN (1) | CN1125877C (es) |
| AT (1) | ATE210185T1 (es) |
| CA (1) | CA2190860A1 (es) |
| DE (1) | DE69524407T2 (es) |
| DK (1) | DK0763114T3 (es) |
| ES (1) | ES2170152T3 (es) |
| FI (1) | FI112249B (es) |
| MX (1) | MX9605666A (es) |
| NO (1) | NO323849B1 (es) |
| NZ (1) | NZ288000A (es) |
| PT (1) | PT763114E (es) |
| WO (1) | WO1995032291A2 (es) |
Families Citing this family (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6156495A (en) * | 1994-02-14 | 2000-12-05 | Abbott Laboratories | Hepatitis GB virus recombinant proteins and uses thereof |
| US6720166B2 (en) | 1994-02-14 | 2004-04-13 | Abbott Laboratories | Non-a, non-b, non-c, non-c, non-d, non-e hepatitis reagents and methods for their use |
| US5843450A (en) * | 1994-02-14 | 1998-12-01 | Abbott Laboratories | Hepatitis GB Virus synthetic peptides and uses thereof |
| US6451578B1 (en) | 1994-02-14 | 2002-09-17 | Abbott Laboratories | Non-A, non-B, non-C, non-D, non-E hepatitis reagents and methods for their use |
| US5981172A (en) * | 1994-02-14 | 1999-11-09 | Abbott Laboratories | Non-A, non-B, non-C, non-D, non-E Hepatitis reagents and methods for their use |
| US6558898B1 (en) | 1994-02-14 | 2003-05-06 | Abbott Laboratories | Non-A, non-B, non-C, non-D, non-E hepatitis reagents and methods for their use |
| US6586568B1 (en) | 1994-02-14 | 2003-07-01 | Abbott Laboratories | Non-A, non-B, non-C, non-D, non-E hepatitis reagents and methods for their use |
| US6051374A (en) * | 1994-02-14 | 2000-04-18 | Abbott Laboratories | Non-A, non-B, non-C, non-D, non-E hepatitis reagents and methods for their use |
| US5807670A (en) * | 1995-08-14 | 1998-09-15 | Abbott Laboratories | Detection of hepatitis GB virus genotypes |
| US5955318A (en) * | 1995-08-14 | 1999-09-21 | Abbott Laboratories | Reagents and methods useful for controlling the translation of hepatitis GBV proteins |
| US5709997A (en) * | 1995-08-14 | 1998-01-20 | Abbott Laboratories | Nucleic acid detection of hepatitis GB virus |
| WO1997019195A1 (de) * | 1995-11-21 | 1997-05-29 | Boehringer Mannheim Gmbh | Amplifikation von nukleinsäuren und nachweis eines neuen hepatitis-nona/nonb/nonc/nond/none-virus |
| IT1283893B1 (it) * | 1996-01-24 | 1998-05-07 | Sorin Biomedica Diagnostics Sp | Metodo per rilevare sequenze nucleotidiche di virus associati a epatiti nona-none, peptidi e composizioni |
| DE19613406A1 (de) * | 1996-04-03 | 1997-10-09 | Boehringer Mannheim Gmbh | Expression von HGV-Antigenen und deren Verwendung |
| IT1284630B1 (it) * | 1996-04-17 | 1998-05-21 | Sorin Biomedica Diagnostics Sp | Epitopi specifici di virus associati a epatiti non"a"-non"e", composizioni e metodo per rivelare anticorpi di detti epitopi. |
| US5766916A (en) * | 1996-04-24 | 1998-06-16 | Genelabs Technologies, Inc. | Hepatitis G virus protease |
| US6020195A (en) * | 1996-09-18 | 2000-02-01 | Roche Diagnostics Gmbh | Antibodies against hepatitis G virus and their use for the diagnostic detection of HGV and as a therapeutic agent |
| WO1999024466A2 (en) * | 1997-11-06 | 1999-05-20 | Innogenetics N.V. | Multi-mer peptides derived from hepatitis c virus envelope proteins for diagnostic use and vaccination purposes |
| GB0009756D0 (en) * | 2000-04-19 | 2000-06-07 | Glaxo Group Ltd | Test method |
| WO2014097762A1 (ja) * | 2012-12-20 | 2014-06-26 | 国立大学法人熊本大学 | 高病原性トリインフルエンザに対する抗体 |
| US9594163B2 (en) | 2013-04-15 | 2017-03-14 | Electronics And Telecommunications Research Institute | Security and surveillance system and method |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1990000597A1 (en) * | 1988-07-06 | 1990-01-25 | Genelabs Incorporated | Post-transfusion, non-a, non-b hepatitis virus and antigens |
| WO1994018217A1 (en) * | 1993-02-03 | 1994-08-18 | Abbott Laboratories | Non-a, non-b, non-c, non-d, non-e hepatitis reagents and methods for their use |
| WO1995021922A2 (en) * | 1994-02-14 | 1995-08-17 | Abbott Laboratories | Non-a, non-b, non-c, non-d, non-e hepatitis reagents and methods for their use |
-
1995
- 1995-05-19 ES ES95922085T patent/ES2170152T3/es not_active Expired - Lifetime
- 1995-05-19 CN CN95194249A patent/CN1125877C/zh not_active Expired - Fee Related
- 1995-05-19 AT AT95922085T patent/ATE210185T1/de not_active IP Right Cessation
- 1995-05-19 EP EP95922085A patent/EP0763114B1/en not_active Expired - Lifetime
- 1995-05-19 MX MX9605666A patent/MX9605666A/es unknown
- 1995-05-19 DE DE69524407T patent/DE69524407T2/de not_active Expired - Fee Related
- 1995-05-19 CA CA002190860A patent/CA2190860A1/en not_active Abandoned
- 1995-05-19 DK DK95922085T patent/DK0763114T3/da active
- 1995-05-19 JP JP7530387A patent/JPH10503642A/ja not_active Withdrawn
- 1995-05-19 PT PT95922085T patent/PT763114E/pt unknown
- 1995-05-19 KR KR1019960706582A patent/KR100394693B1/ko not_active Expired - Fee Related
- 1995-05-19 WO PCT/US1995/006169 patent/WO1995032291A2/en not_active Ceased
- 1995-06-22 NZ NZ288000A patent/NZ288000A/en not_active IP Right Cessation
-
1996
- 1996-11-07 NO NO19964721A patent/NO323849B1/no not_active IP Right Cessation
- 1996-11-18 FI FI964605A patent/FI112249B/fi active
-
2005
- 2005-11-02 JP JP2005320175A patent/JP4296174B2/ja not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| KR100394693B1 (ko) | 2003-12-31 |
| ATE210185T1 (de) | 2001-12-15 |
| KR970703425A (ko) | 1997-07-03 |
| JP4296174B2 (ja) | 2009-07-15 |
| DE69524407T2 (de) | 2002-08-01 |
| PT763114E (pt) | 2002-05-31 |
| FI964605A0 (fi) | 1996-11-18 |
| CN1153529A (zh) | 1997-07-02 |
| AU2689595A (en) | 1995-12-18 |
| JP2006115845A (ja) | 2006-05-11 |
| DK0763114T3 (da) | 2002-04-02 |
| NO964721D0 (no) | 1996-11-07 |
| JPH10503642A (ja) | 1998-04-07 |
| EP0763114A2 (en) | 1997-03-19 |
| WO1995032291A3 (en) | 1996-03-07 |
| NZ288000A (en) | 1998-09-24 |
| EP0763114B1 (en) | 2001-12-05 |
| NO323849B1 (no) | 2007-07-09 |
| CN1125877C (zh) | 2003-10-29 |
| NO964721L (no) | 1997-01-17 |
| CA2190860A1 (en) | 1995-11-30 |
| HK1012412A1 (en) | 1999-07-30 |
| DE69524407D1 (de) | 2002-01-17 |
| FI112249B (fi) | 2003-11-14 |
| WO1995032291A2 (en) | 1995-11-30 |
| MX9605666A (es) | 1998-05-31 |
| AU684177B2 (en) | 1997-12-04 |
| FI964605L (fi) | 1997-01-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| UA42668C2 (uk) | Поліпептид, що має антигенні властивості вірусу гепатиту с (hcv) (варіанти), діагностичний реагент для виявлення антитіл до вірусу гепатиту с (варіанти), набір для виявлення антитіл до вірусу гепатиту с (варіанти), спосіб виявлення антитіл до вірусу гепатиту с (варіанти) | |
| ATE127517T1 (de) | Verfahren und produkte zur feststellung von menschlichem t-zellen-leukämie-virus. | |
| DE69111801D1 (de) | Vakzin gegen hepatitis b. | |
| ES2101388T3 (es) | Antigenos sinteticos para la deteccion de anticuerpos para el virus de la hepatitis c. | |
| FI964605A0 (fi) | Hepatiitti-G virus ja sen molekyylikloonaus | |
| KR920701481A (ko) | 장을 통해 전염되는 비a비b형 간염 바이러스 병원체 및 그것의 특유한 에피토프 | |
| NO900474D0 (no) | Bukspyttkjertel-islet-celleantigener tilveiebragt ved molekylaer kloning. | |
| ATE109512T1 (de) | Expression und diagnose mit gag-kodierten peptiden, die mit antikörpern gegen lav immunologisch reaktiv sind. | |
| WO2003012395A3 (en) | Early detection of mycobacterial disease using peptides | |
| Barron et al. | Demonstration of human measles antibody by mixed agglutination | |
| DK0491713T3 (da) | Rubella El-peptider og C-peptider | |
| ATE212129T1 (de) | Präsentation von aus lipoarabinomannan bestehenden antigenen an t-zellen durch cd1 moleküle | |
| SE8704765L (sv) | Immunologiskt aktiva polypeptider, anvendbara for framstellning av antimalariavacciner och diagnostest for pavisande av antisporozoantikroppar | |
| DK218886A (da) | Tvaerreaktive og beskyttende epitoper af circumsporozoit-proteiner | |
| DK1044377T3 (da) | Fremgangsmåde til påvisning af Borna disease virus (BDV)-infektioner | |
| SE9101863D0 (sv) | Peptider, diagnostiskt antigen, vaccinkomposition och foerfarande foer selektering av hiv-stammar | |
| Fernando et al. | Precipitin reactions in monkeys (Macaca sinica) experimentally infected with Toxocara canis and in children with visceral larva migrans syndrome | |
| GR890100219A (el) | Ανθρωπινα μονοκλωνικα αντισωματα που ειδικα αναγνωριζουν κυτταραιου λυσσας κυτταρα που παραγουν τα ιδια, διαμορφωσεις που περιε χουν τα ιδια και παραγωγη ολων αυτων. | |
| Pauli et al. | Antigenic components of Aujeszky’s disease virus | |
| NZ331889A (en) | Trypanosomatids histones for use as an antigen against trypanosomatic infection, including diagnostic tests, pharmaceutical compositions and vaccines of these antigens | |
| Aouni et al. | Detection of antibodies against initial polypeptides in patients infected with an enterovirus (EV-33) | |
| Tiwari et al. | Single radial haemolysis for the detection of goat pox virus antigen and antibody | |
| Gonzalez-Juarrero et al. | Porcine lymphocyte gamma interferon responses to mitogenic stimuli monitored by a direct immunoassay | |
| Cruceanu et al. | Some particularities of hepatitis B-antigen subdeterminants | |
| Marshall Jr et al. | Comparison of the reliability and sensitivity of three serological procedures in detecting antibody to Yersinia pestis (Pasteurella pestis) |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG2A | Definitive protection |
Ref document number: 763114 Country of ref document: ES |